Armenia vs Syrian Arab Republic: Reported versus estimated cases of polio
Armenia
0 cases
in 2023
Syrian Arab Republic
0 cases
in 2023
Armenia rank
26th
Syrian Arab Republic rank
26th
Reported versus estimated cases of polio over time
- Armenia
- Syrian Arab Republic
How they compare
Armenia currently reports 0 cases against 0 cases in Syrian Arab Republic, a difference of 0 cases.
The two have swapped places 2 times across 33 shared years of data; in 1991 it was Syrian Arab Republic ahead.
Armenia ranks 26th and Syrian Arab Republic ranks 26th of 199 countries.
Syrian Arab Republic has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Armenia | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.33 cases | 5.89 cases | 4.56 cases | Syrian Arab Republic |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0 cases | 11 cases | 11 cases | Syrian Arab Republic |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported versus estimated cases of polio, Armenia or Syrian Arab Republic?
- Armenia, at 0 cases against 0 cases in Syrian Arab Republic as of 2023.
- What is the difference in reported versus estimated cases of polio between Armenia and Syrian Arab Republic?
- 0 cases, with Armenia ahead.
- How many years of comparable data are there for Armenia and Syrian Arab Republic?
- 33 years are reported by both, from 1991 to 2023.
- How do Armenia and Syrian Arab Republic rank globally for reported versus estimated cases of polio?
- Armenia ranks 26th and Syrian Arab Republic ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported versus estimated cases of polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.